Biochemical studies have revealed that the expressions of GAD65/67 are decreased in the CB of subjects with developmental disorders such as autism and schizophrenia (Bullock et al., 2008; Blatt and Fatemi, 2011). This evidence concerns the gene GAD2 and schizophrenia.